Begin typing your search above and press return to search.

Zydus hypertension drug gets US regulatory nod

Sentinel Digital DeskBy : Sentinel Digital Desk

  |  25 Sep 2017 12:00 AM GMT

Ahmedabad, Sept 24: Global healthcare provider Zydus Cadila on Saturday said it received approval from the US Federal Drug Authority (USFDA) to market Amlodipine and Olmesartan Medoxomil tablets for the treatment of hypertension.

“The drug, meant for treating hypertension or to lower blood pressure with other anti-hypertensive agents, will be manufactured at our group’s formulations manufacturing facility at the Pharma SEZ in Ahmedabad,” said the company in a regulatory filing to the BSE.

The company also received the federal regulatory approval on September 21 to market its Itracozole capsules to treat fungal infections. (IANS)

Next Story